Mochida Pharmaceutical Co., Ltd. (TYO:4534)
3,180.00
+60.00 (1.92%)
Aug 4, 2026, 9:03 AM JST
Mochida Pharmaceutical Market Cap
Mochida Pharmaceutical has a market cap or net worth of 112.64 billion as of August 3, 2026. Its market cap has decreased by -1.63% in one year.
Market Cap
112.64B
Enterprise Value
94.23B
Revenue
116.95B
Ranking
n/a
PE Ratio
14.26
Stock Price
3,180.00
ChartMarket Cap Chart
Since August 18, 1993, Mochida Pharmaceutical's market cap has decreased from 274.13B to 112.64B, a decrease of -58.91%. That is a compound annual growth rate of -2.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 112.64B | -10.12% |
| Dec 30, 2025 | 125.32B | 0.42% |
| Dec 30, 2024 | 124.79B | 7.13% |
| Dec 29, 2023 | 116.48B | -9.47% |
| Dec 30, 2022 | 128.67B | -3.10% |
| Dec 30, 2021 | 132.79B | -12.14% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tsumura & Co. | 282.53B |
| Nippon Shinyaku | 230.92B |
| Towa Pharmaceutical | 197.16B |
| Sawai Group Holdings | 186.68B |
| Kissei Pharmaceutical | 169.33B |
| Kaken Pharmaceutical | 143.71B |
| Zeria Pharmaceutical | 92.13B |
| KYORIN Pharmaceutical | 64.01B |